Alyeska Investment Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20,400
| Closed | -$315K | – | 612 |
|
|
2023
Q1 | $315K | Buy |
+20,400
| New | +$315K | ﹤0.01% | 400 |
|
|
2021
Q3 | – | Sell |
-142,932
| Closed | -$5.23M | – | 825 |
|
|
2021
Q2 | $5.23M | Sell |
142,932
-25,000
| -15% | -$915K | 0.06% | 330 |
|
|
2021
Q1 | $7.53M | Buy |
167,932
+51,339
| +44% | +$2.3M | 0.1% | 244 |
|
|
2020
Q4 | $6.65M | Sell |
116,593
-35,376
| -23% | -$2.02M | 0.09% | 233 |
|
|
2020
Q3 | $7.8M | Buy |
151,969
+70,523
| +87% | +$3.62M | 0.12% | 210 |
|
|
2020
Q2 | $4.86M | Buy |
81,446
+56,446
| +226% | +$3.37M | 0.07% | 266 |
|
|
2020
Q1 | $1.03M | Buy |
+25,000
| New | +$1.03M | 0.02% | 278 |
|
|
2019
Q4 | – | Sell |
-162,993
| Closed | -$5.53M | – | 478 |
|
|
2019
Q3 | $5.53M | Buy |
162,993
+23,802
| +17% | +$808K | 0.08% | 210 |
|
|
2019
Q2 | $3.14M | Buy |
139,191
+85,910
| +161% | +$1.94M | 0.04% | 259 |
|
|
2019
Q1 | $1.24M | Sell |
53,281
-39,719
| -43% | -$922K | 0.02% | 272 |
|
|
2018
Q4 | $1.95M | Sell |
93,000
-48,607
| -34% | -$1.02M | 0.03% | 259 |
|
|
2018
Q3 | $5.48M | Hold |
141,607
| – | – | 0.06% | 217 |
|
|
2018
Q2 | $5.57M | Buy |
141,607
+66,278
| +88% | +$2.61M | 0.05% | 253 |
|
|
2018
Q1 | $1.51M | Sell |
75,329
-25,086
| -25% | -$503K | 0.01% | 339 |
|
|
2017
Q4 | $2.28M | Sell |
100,415
-3,235
| -3% | -$73.3K | 0.02% | 300 |
|
|
2017
Q3 | $1.97M | Buy |
+103,650
| New | +$1.97M | 0.01% | 342 |
|